| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Dobmeier Eric is a Director at Atara Biotherapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 4 buys and 11 sells.
Estimated insider holdings value: $4.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2023 | ATRA Atara Biotherapeutics, Inc. | - | Buy | 446,825 | $0.23 | $101,339.91 | +383.5% | +259.4% | +96.9% | |
| Jan 4, 2021 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 10,000 | $57.34 | $573,368.94 | -55.2% | - | - | |
| Oct 1, 2020 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 10,000 | $48.53 | $485,274.24 | -92.8% | - | - | |
| Jul 6, 2020 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 10,000 | $47.37 | $473,656.00 | -96.2% | - | - | |
| Jun 3, 2020 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 5,000 | $39.79 | $198,950.00 | -100% | - | - | |
| May 19, 2020 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 5,000 | $40.00 | $200,000.00 | -100% | - | - | |
| May 7, 2020 | ADPT Adaptive Biotechnologies Corp | Director | Sale+OE | 5,000 | $35.00 | $175,000.00 | -100% | - | - | |
| Jun 27, 2019 | ATRA Atara Biotherapeutics, Inc. | Director | Buy | 2,000 | $19.50 | $39,000.00 | +14.3% | - | - | |
| Mar 17, 2016 | ATRA Atara Biotherapeutics, Inc. | Director | Buy | 3,000 | $13.86 | $41,565.00 | +120.0% | - | - | |
| Dec 16, 2015 | ATRA Atara Biotherapeutics, Inc. | Director | Buy | 2,500 | $22.00 | $55,000.00 | New | - | - |